A staple reagent in immunology research, particularly in the study of SARS-CoV-2, this Anti-Sars-Cov-2 Spike Glycoprotein RBD Antibody [5G8] is a valuable tool for scientists working in the field of organic synthesis and formulation chemistry. This unconjugated, monoclonal IgG1 antibody specifically targets the Receptor Binding Domain (RBD) of the SARS-CoV-2 Spike Glycoprotein, making it ideal for Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry/Immunofluorescence (ICC/IF) applications. Purified through immunogen affinity purification, this antibody is host-species specific, originating from mice. It exhibits reactivity towards SARS-CoV-2, ensuring its efficacy in various research settings. Proper storage at +4 °C is recommended to maintain its density of 1 g/cm³.

• Category: Primary Antibodies
• Target: SARS-CoV-2 Spike Glycoprotein RBD
• Conjugate: uncojugated
• Purification: Immunogen affinity purification
• Clonality: monoclonal
• Host species: mouse
• Density (D): 1 g/cm³
• Reactivity antibody: SARS-CoV-2
• Clone: 5G8
• Application: WB IHC ICC/IF
• Storage temp.: +4 °C
• Isotype: IgG1